Find a Clinical Trial

Find a Clinical Trial

Search by practice name, trial titles, indicators and specific disease types.

Lymphomas

Clinical Trial at: Texas Oncology - Allen

(SGN35-015) A phase 2 open-label study of brentuximab vedotin in front-line therapy of Hodgkin lymphoma (HL) and CD30-expressing peripheral T-cell lymphoma (PTCL) in older patients or patients with significant comorbidities ineligible for standard chemotherapy

  • Details

ClinicalTrials.gov ID: NCT01716806
Diagnosis Type: Non-Hodgkins
USOR Number: 11282

  • Practice Details

1105 Central Expressway, Suite 320
Allen, Texas 75013
279.71 mi. away
P: (469) 467-4392

More Details View Practice Page

Lung Cancer

Clinical Trial at: Texas Oncology - Allen

A Randomized, Open-Label, Phase 3 Study of Pralsetinib versus Standard of Care for First Line Treatment of RET fusion-positive, Metastatic Non-Small Cell Lung Cancer (BLU-667-2303)

  • Details

ClinicalTrials.gov ID: NCT04222972
Diagnosis Type: NA
USOR Number: 19208

  • Practice Details

1105 Central Expressway, Suite 320
Allen, Texas 75013
279.71 mi. away
P: (469) 467-4392

More Details View Practice Page

Lung Cancer

Clinical Trial at: Texas Oncology - Allen

A Randomized, Open-Label, Phase 3 Study of Pralsetinib versus Standard of Care for First Line Treatment of RET fusion-positive, Metastatic Non-Small Cell Lung Cancer (BLU-667-2303)

  • Details

ClinicalTrials.gov ID: NCT04222972
Diagnosis Type: NA
USOR Number: 19208

  • Practice Details

1105 Central Expressway, Suite 320
Allen, Texas 75013
279.71 mi. away
P: (469) 467-4392

More Details View Practice Page

Myelofibrosis

Clinical Trial at: Texas Oncology - Allen

A Randomized, Controlled Phase 3 Study of Pacritinib Versus Physician's Choice in Patients with Primary Myelofibrosis, Post Polycythemia Vera Myelofibrosis, or Post-Essential Thrombocythemia Myelofibrosis with Severe Thrombocytopenia (Platelets Counts <50,000/µL) (PAC203)

  • Details

ClinicalTrials.gov ID: NCT03165734
Diagnosis Type: NA
USOR Number: 19171

  • Practice Details

1105 Central Expressway, Suite 320
Allen, Texas 75013
279.71 mi. away
P: (469) 467-4392

More Details View Practice Page

Essential Thrombocythemia

Clinical Trial at: Texas Oncology - Allen

A Randomized, Controlled Phase 3 Study of Pacritinib Versus Physician's Choice in Patients with Primary Myelofibrosis, Post Polycythemia Vera Myelofibrosis, or Post-Essential Thrombocythemia Myelofibrosis with Severe Thrombocytopenia (Platelets Counts <50,000/µL) (PAC203)

  • Details

ClinicalTrials.gov ID: NCT03165734
Diagnosis Type: NA
USOR Number: 19171

  • Practice Details

1105 Central Expressway, Suite 320
Allen, Texas 75013
279.71 mi. away
P: (469) 467-4392

More Details View Practice Page

Myelofibrosis

Clinical Trial at: Texas Oncology - Allen

A Randomized, Controlled Phase 3 Study of Pacritinib Versus Physician's Choice in Patients with Primary Myelofibrosis, Post Polycythemia Vera Myelofibrosis, or Post-Essential Thrombocythemia Myelofibrosis with Severe Thrombocytopenia (Platelets Counts <50,000/µL) (PAC203)

  • Details

ClinicalTrials.gov ID: NCT03165734
Diagnosis Type: NA
USOR Number: 19171

  • Practice Details

1105 Central Expressway, Suite 320
Allen, Texas 75013
279.71 mi. away
P: (469) 467-4392

More Details View Practice Page

Essential Thrombocythemia

Clinical Trial at: Texas Oncology - Allen

A Randomized, Controlled Phase 3 Study of Pacritinib Versus Physician's Choice in Patients with Primary Myelofibrosis, Post Polycythemia Vera Myelofibrosis, or Post-Essential Thrombocythemia Myelofibrosis with Severe Thrombocytopenia (Platelets Counts <50,000/µL) (PAC203)

  • Details

ClinicalTrials.gov ID: NCT03165734
Diagnosis Type: NA
USOR Number: 19171

  • Practice Details

1105 Central Expressway, Suite 320
Allen, Texas 75013
279.71 mi. away
P: (469) 467-4392

More Details View Practice Page

Lymphomas

Clinical Trial at: Texas Oncology - Allen

A Phase 3, Randomized Study of Zanubrutinib (BGB-3111) Compared with Ibrutinib in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma (BGB-3111-305)

  • Details

ClinicalTrials.gov ID: NCT03734016
Diagnosis Type: NA
USOR Number: 18155

  • Practice Details

1105 Central Expressway, Suite 320
Allen, Texas 75013
279.71 mi. away
P: (469) 467-4392

More Details View Practice Page

Leukemia

Clinical Trial at: Texas Oncology - Allen

A Phase 3, Randomized Study of Zanubrutinib (BGB-3111) Compared with Ibrutinib in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma (BGB-3111-305)

  • Details

ClinicalTrials.gov ID: NCT03734016
Diagnosis Type: NA
USOR Number: 18155

  • Practice Details

1105 Central Expressway, Suite 320
Allen, Texas 75013
279.71 mi. away
P: (469) 467-4392

More Details View Practice Page

Prostate Cancer

Clinical Trial at: Texas Oncology - Allen

Biomarker Study to Determine Frequency of DNA-repair Defects in Men with Metastatic Prostate Cancer (64091742PCR0002)

  • Details

ClinicalTrials.gov ID: NCT03871816
Diagnosis Type: NA
USOR Number: 19144

  • Practice Details

1105 Central Expressway, Suite 320
Allen, Texas 75013
279.71 mi. away
P: (469) 467-4392

More Details View Practice Page

Solid Tumors

Clinical Trial at: Texas Oncology - Allen

A Phase 2 Study of Erdafitinib in Subjects With Advanced Solid Tumors and FGFR Gene Alterations (42756493CAN2002)

  • Details

ClinicalTrials.gov ID: NCT04083976
Diagnosis Type: NA
USOR Number: 19092

  • Practice Details

1105 Central Expressway, Suite 320
Allen, Texas 75013
279.71 mi. away
P: (469) 467-4392

More Details View Practice Page

Solid Tumors

Clinical Trial at: Texas Oncology - Allen

A Phase 2 Study of Erdafitinib in Subjects With Advanced Solid Tumors and FGFR Gene Alterations (42756493CAN2002)

  • Details

ClinicalTrials.gov ID: NCT04083976
Diagnosis Type: NA
USOR Number: 19092

  • Practice Details

1105 Central Expressway, Suite 320
Allen, Texas 75013
279.71 mi. away
P: (469) 467-4392

More Details View Practice Page

Breast Cancer

Clinical Trial at: Texas Oncology - Allen

STAR: Randomized, double-blind, phase 3 study of tucatinib or placebo in combination with ado-trastuzumab emtansine (T-DM1) for subjects with unresectable locally-advanced or metastatic HER2+ breast cancer (HER2CLIMB-02)(SGNTUC-016)

  • Details

ClinicalTrials.gov ID: NCT03975647
Diagnosis Type: NA
USOR Number: 19054

  • Practice Details

1105 Central Expressway, Suite 320
Allen, Texas 75013
279.71 mi. away
P: (469) 467-4392

More Details View Practice Page

Breast Cancer

Clinical Trial at: Texas Oncology - Allen

STAR: Randomized, double-blind, phase 3 study of tucatinib or placebo in combination with ado-trastuzumab emtansine (T-DM1) for subjects with unresectable locally-advanced or metastatic HER2+ breast cancer (HER2CLIMB-02)(SGNTUC-016)

  • Details

ClinicalTrials.gov ID: NCT03975647
Diagnosis Type: NA
USOR Number: 19054

  • Practice Details

1105 Central Expressway, Suite 320
Allen, Texas 75013
279.71 mi. away
P: (469) 467-4392

More Details View Practice Page

Urothelial Cancer

Clinical Trial at: Texas Oncology - Allen

(42756493BLC3001) A Phase 3 Study of Erdafitinib Compared with Vinflunine or Docetaxel or Pembrolizumab in Subjects with Advanced Urothelial Cancer and Selected FGFR Gene Aberrations (THOR)

  • Details

ClinicalTrials.gov ID: NCT03390504
Diagnosis Type: NA
USOR Number: 17133

  • Practice Details

1105 Central Expressway, Suite 320
Allen, Texas 75013
279.71 mi. away
P: (469) 467-4392

More Details View Practice Page

Urothelial Cancer

Clinical Trial at: Texas Oncology - Allen

(42756493BLC3001) A Phase 3 Study of Erdafitinib Compared with Vinflunine or Docetaxel or Pembrolizumab in Subjects with Advanced Urothelial Cancer and Selected FGFR Gene Aberrations (THOR)

  • Details

ClinicalTrials.gov ID: NCT03390504
Diagnosis Type: NA
USOR Number: 17133

  • Practice Details

1105 Central Expressway, Suite 320
Allen, Texas 75013
279.71 mi. away
P: (469) 467-4392

More Details View Practice Page

Biliary Cancer

Clinical Trial at: Texas Oncology - Allen

A Phase 3 Multicenter, Open-Label, Randomized, Controlled Study of Oral Infigratinib versus Gemcitabine with Cisplatin in Subjects with Advanced/Metastatic or Inoperable Cholangiocarcinoma with FGFR2 Gene Fusions/Translocations: The PROOF Trial (QBGJ398-301)

  • Details

ClinicalTrials.gov ID: NCT03773302
Diagnosis Type: NA
USOR Number: 18264

  • Practice Details

1105 Central Expressway, Suite 320
Allen, Texas 75013
279.71 mi. away
P: (469) 467-4392

More Details View Practice Page

Biliary Cancer

Clinical Trial at: Texas Oncology - Allen

A Phase 3 Multicenter, Open-Label, Randomized, Controlled Study of Oral Infigratinib versus Gemcitabine with Cisplatin in Subjects with Advanced/Metastatic or Inoperable Cholangiocarcinoma with FGFR2 Gene Fusions/Translocations: The PROOF Trial (QBGJ398-301)

  • Details

ClinicalTrials.gov ID: NCT03773302
Diagnosis Type: NA
USOR Number: 18264

  • Practice Details

1105 Central Expressway, Suite 320
Allen, Texas 75013
279.71 mi. away
P: (469) 467-4392

More Details View Practice Page

Solid Tumors

Clinical Trial at: Texas Oncology - Allen

(INCB 54828-207) A Phase 2, Open-Label, Single-Arm, Multicenter Study to Evaluate the Efficacy and Safety of Pemigatinib in Participants With Previously Treated Locally Advanced/Metastatic or Surgically Unresectable Solid Tumor Malignancies Harboring Activating FGFR Mutations or Translocations (FIGHT-207)

  • Details

ClinicalTrials.gov ID: NCT03822117
Diagnosis Type: NA
USOR Number: 19079

  • Practice Details

1105 Central Expressway, Suite 320
Allen, Texas 75013
279.71 mi. away
P: (469) 467-4392

More Details View Practice Page

Solid Tumors

Clinical Trial at: Texas Oncology - Allen

(INCB 54828-207) A Phase 2, Open-Label, Single-Arm, Multicenter Study to Evaluate the Efficacy and Safety of Pemigatinib in Participants With Previously Treated Locally Advanced/Metastatic or Surgically Unresectable Solid Tumor Malignancies Harboring Activating FGFR Mutations or Translocations (FIGHT-207)

  • Details

ClinicalTrials.gov ID: NCT03822117
Diagnosis Type: NA
USOR Number: 19079

  • Practice Details

1105 Central Expressway, Suite 320
Allen, Texas 75013
279.71 mi. away
P: (469) 467-4392

More Details View Practice Page

Pages